These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3765578)

  • 1. [Effect of carsil and legalon in treating chronic liver diseases].
    Brailski Kh; Chernev K; Etŭrska M; Donov M; Velev G
    Vutr Boles; 1986; 25(3):43-9. PubMed ID: 3765578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the Romanian product Silimarina in the treatment of chronic liver diseases.
    Tănăsescu C; Petrea S; Băldescu R; Macarie E; Chiriloiu C; Purice S
    Med Interne; 1988; 26(4):311-22. PubMed ID: 3072661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical investigation of silymarin in chronic liver diseases (author's transl)].
    Realini S; Gonvers JJ; Hofstetter JR
    Schweiz Rundsch Med Prax; 1975 May; 64(19):595-8. PubMed ID: 51497
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
    Reutter FW; Haase W
    Schweiz Rundsch Med Prax; 1975 Sep; 64(36):1145-51. PubMed ID: 1099576
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions].
    Maleev A; Tsvetkova V; Krŭstev Z; Kostova N; Lukanov L
    Vutr Boles; 1985; 24(5):39-43. PubMed ID: 4090451
    [No Abstract]   [Full Text] [Related]  

  • 6. [Silymarin in chronic liver diseases].
    Müscher CH
    Ther Ggw; 1972 Dec; 111(12):1768-70 passim. PubMed ID: 4569030
    [No Abstract]   [Full Text] [Related]  

  • 7. [Liver-protective action of silymarin therapy in chronic alcoholic liver diseases].
    Fehér J; Deák G; Müzes G; Láng I; Niederland V; Nékám K; Kárteszi M
    Orv Hetil; 1989 Dec; 130(51):2723-7. PubMed ID: 2574842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Silymarin for the treatment of acute viral hepatitis? Report of a controlled trial (author's transl)].
    Bode JC; Schmidt U; Dürr HK
    Med Klin; 1977 Mar; 72(12):513-8. PubMed ID: 840125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Searching for a new therapeutic principle. Experience with hepatic therapeutic agent Legalon].
    Schopen RD; Lange OK; Panne C; Kirnberger EJ
    Med Welt; 1969 Apr; 20(15):888-93. PubMed ID: 5784376
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of chronic diseases of the liver with catergen].
    Loginov AS; Dzhalalov KD; Blok IuE; Bendikov EA; Ausheva LKh
    Ter Arkh; 1986; 58(2):73-6. PubMed ID: 3704945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunomodulator effect of silymarin therapy in chronic alcoholic liver diseases].
    Deák G; Müzes G; Láng I; Niederland V; Nékám K; Gonzalez-Cabello R; Gergely P; Fehér J
    Orv Hetil; 1990 Jun; 131(24):1291-2, 1295-6. PubMed ID: 2195425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of Legalon in non-alcoholic fatty liver disease].
    Buturova LI; Tsybizova TA; Kalinin AV
    Eksp Klin Gastroenterol; 2010; (5):69-75. PubMed ID: 20734480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antioxidant activity of hepatotropic preparations in the treatment of chronic diseases of the liver].
    Loginov AS; Matiushin BN; Sukhareva GV; Tkachev VD
    Ter Arkh; 1988; 60(8):74-7. PubMed ID: 3227482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of the analogue of natural Schisandrin C (HpPro) in treatment of liver diseases: an experience in Indonesian patients.
    Akbar N; Tahir RA; Santoso WD; Soemarno ; Sumaryono ; Noer HM; Liu G
    Chin Med J (Engl); 1998 Mar; 111(3):248-51. PubMed ID: 10374427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparations of alpha-lipoic acid: the dynamics of their content in the blood and their effect on hemostasis in lesions of the human liver].
    Loginov AS; Nilova TV; Bendikov EA; Petrakov AV
    Farmakol Toksikol; 1990; 53(2):47-50. PubMed ID: 2115010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Legalon in the complex treatment of patients with hepatic stasis in chronic circulatory insufficiency].
    Krylov AA
    Vrach Delo; 1984 Mar; (3):22-3. PubMed ID: 6719894
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of hemosorption in the treatment of patients with chronic liver diseases].
    Radchenko VG; Litvinov AS; Vinogradova GL
    Ter Arkh; 1987; 59(2):118-21. PubMed ID: 3576464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Catergen [(+)cyanidanol-3] on some haemostatic parameters in chronic liver diseases.
    Pfliegler G; Boda Z; Dalmi L; Weisz G; Misz M; Beck P
    Ther Hung; 1984; 32(1):19-25. PubMed ID: 6571189
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lecithin-cholesterol-acyltransferase activity in chronic liver diseases].
    Gaskina TK; Dolgov AV; Kurilovich SA
    Vopr Med Khim; 1987; 33(4):96-9. PubMed ID: 3660750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.